Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer

NCT00003276 ·Status: COMPLETED ·Phase: PHASE2

Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy

NCT00940758 ·Status: COMPLETED ·Phase: PHASE1

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

NCT00022698 ·Status: COMPLETED ·Phase: PHASE2

Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver

NCT02110953 ·Status: TERMINATED ·Phase: PHASE1

NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer

NCT00856375 ·Status: COMPLETED ·Phase: PHASE2

Irinotecan in Treating Patients With Metastatic Colorectal Cancer

NCT00003544 ·Status: COMPLETED ·Phase: PHASE2

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

NCT02703571 ·Status: TERMINATED ·Phase: PHASE1

A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer

NCT00730158 ·Status: COMPLETED ·Phase: PHASE2

Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer

NCT03785873 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases

NCT07321847 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer

NCT00005818 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Irinotecan in Treating Patients With Colorectal Cancer

NCT00003843 ·Status: TERMINATED

Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients

NCT03053167 ·Status: UNKNOWN ·Phase: PHASE2

Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

NCT03567629 ·Status: UNKNOWN ·Phase: PHASE2

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

NCT03758781 ·Status: COMPLETED ·Phase: PHASE1

Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer

NCT01322152 ·Status: COMPLETED ·Phase: PHASE2

Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors

NCT03878095 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab

NCT00588900 ·Status: TERMINATED ·Phase: PHASE2

A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy

NCT02053376 ·Status: COMPLETED ·Phase: PHASE2

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

NCT00037180 ·Status: TERMINATED ·Phase: PHASE2

Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy

NCT00336856 ·Status: COMPLETED ·Phase: PHASE2

ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer

NCT00004193 ·Status: TERMINATED ·Phase: PHASE2

S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer

NCT02164916 ·Status: COMPLETED ·Phase: PHASE2

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

NCT01923337 ·Status: COMPLETED ·Phase: PHASE1

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

NCT00838578 ·Status: TERMINATED ·Phase: PHASE1/PHASE2